Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Perrigo Company Public Limited Company
IndexS&P 500 P/E132.31 EPS (ttm)1.50 Insider Own0.10% Shs Outstand146.26M Perf Week2.04%
Market Cap29.03B Forward P/E22.35 EPS next Y8.88 Insider Trans-9.00% Shs Float145.59M Perf Month-1.57%
Income203.40M PEG10.43 EPS next Q2.01 Inst Own70.30% Short Float1.08% Perf Quarter30.64%
Sales4.22B P/S6.88 EPS this Y-62.00% Inst Trans-7.09% Short Ratio0.75 Perf Half Y25.16%
Book/sh68.08 P/B2.92 EPS next Y16.18% ROA2.00% Target Price197.38 Perf Year45.48%
Cash/sh23.60 P/C8.41 EPS next 5Y12.68% ROE3.30% 52W Range132.45 - 215.73 Perf YTD18.83%
Dividend0.50 P/FCF34.71 EPS past 5Y3.10% ROI2.80% 52W High-8.00% Beta0.24
Dividend %0.25% Quick Ratio3.50 Sales past 5Y15.20% Gross Margin35.60% 52W Low49.85% ATR4.19
Employees10220 Current Ratio4.00 Sales Q/Q4.50% Oper. Margin17.40% RSI (14)67.69 Volatility1.92% 2.26%
OptionableYes Debt/Eq0.49 EPS Q/Q-286.10% Profit Margin7.10% Rel Volume0.37 Prev Close198.26
ShortableYes LT Debt/Eq0.46 EarningsMay 04 BMO Payout19.60% Avg Volume2.09M Price198.47
Recom2.40 SMA203.54% SMA507.43% SMA20022.78% Volume771,409 Change0.11%
Apr-27-15Downgrade B. Riley & Co. Buy → Neutral
Apr-22-15Reiterated B. Riley & Co. Buy $189 → $195
Apr-10-15Downgrade Argus Buy → Hold
Feb-06-15Reiterated RBC Capital Mkts Outperform $177 → $175
Nov-12-14Reiterated Argus Buy $160 → $175
Nov-07-14Reiterated RBC Capital Mkts Outperform $169 → $177
Sep-22-14Reiterated RBC Capital Mkts Outperform $160 → $169
May-15-14Reiterated Argus Buy $175 → $160
May-08-14Reiterated B. Riley & Co. Neutral $170 → $157
May-08-14Downgrade RBC Capital Mkts Top Pick → Outperform $187 → $160
Mar-03-14Reiterated UBS Buy $176 → $190
Mar-03-14Reiterated Stifel Buy $165 → $175
Feb-25-14Reiterated CRT Capital Buy $165 → $175
Feb-07-14Downgrade B. Riley & Co. Buy → Neutral
Jan-16-14Reiterated Argus Buy $160 → $175
Jan-07-14Initiated RBC Capital Mkts Top Pick $187
Dec-12-13Reiterated Stifel Buy $150 → $165
Nov-07-13Reiterated Argus Buy $152 → $160
Nov-04-13Reiterated UBS Buy $140 → $160
Oct-21-13Initiated Argus Buy $152
May-21-15 04:02PM  Energy Stocks Dominating Billionaire Izzy Englanders Top Holdings: NextEra Energy Inc (NEE), Noble Energy, Inc. (NBL), Devon Energy Corp (DVN) at Insider Monkey
May-20-15 09:29AM  10 S&P 500 Companies to Have the Most Revenue Growth in 2015 at TheStreet
May-19-15 07:31PM  Mariko Gordon Sells Lumber Liquidators, Western Digital
08:19AM  Five things to know today, and a big golden parachute in Heinz merger at
May-18-15 01:37PM  Perrigo CEO Says Ready to Talk Deal With Mylan at Right Price at Bloomberg
10:38AM  Endo Buying Par Pharma To Become Top Generics Player at Investor's Business Daily
07:39AM  How to play weak Q2 earnings season: Analysts at CNBC
May-13-15 11:50AM  Perrigo (PRGO) Buys Patheon's Mexican Business for $34M - Analyst Blog
May-12-15 03:23PM  Perrigo expands Mexican business in $34M deal with Pantheon
12:04PM  Perrigo Company To Present At The UBS Global Healthcare Conference PR Newswire
11:42AM  Pharma M&A: Taking stock at Financial Times
09:25AM  Perrigo to Buy Patheon's Mexican Business at The Wall Street Journal
09:06AM  Mylans Share Price Declines 3% on 1Q15 Earnings
08:45AM  Perrigo Acquires Patheon's Mexican Operations PR Newswire
May-11-15 06:36PM  Actavis Earnings Strong, Gives 2015 Guidance
09:05AM  The Many Reasons Mylan Is So Keen to Acquire Perrigo
05:04AM  What Is the Risk-to-Reward on the PerrigoMylan Situation?
04:05AM  How the Mylan Bid Stacks Up to Similar Transactions
04:04AM  Whats the Spread in the PerrigoMylan transaction?
May-08-15 05:00PM  Dealpolitik: Mylan to Investors: We'll Do What We Want at The Wall Street Journal
12:20PM  Horizon Pharma Q1 Mixed, Settles Suit With Perrigo at Investor's Business Daily
May-07-15 05:39PM  Jim Chanos, Kyle Bass Rip Oil And Pharma At SALT 2015
11:12AM  EXCLUSIVE: Hedge funder Kyle Bass is at war with big pharma, but he's long on this one pharma stock
May-06-15 09:42AM  Faber Report: Mylan pushes for Perrigo
07:51AM  Early movers: GEVA, MGI, JPM, WEN, NWSA & more at CNBC
May-05-15 10:01AM  Perrigo Animal Health Launches PetArmor® Joint Health Maximum Supplement for Dogs PR Newswire
May-04-15 04:00PM  Can Mylan (MYL) Specialty Segment Secure Earnings Beat? - Analyst Blog
07:07AM  Q3 2015 Perrigo Company PLC Earnings Release - Before Market Open
May-01-15 02:38PM  Top picks in health care
Apr-30-15 04:57PM  Perrigo Company To Present At Upcoming Healthcare Conferences at noodls
04:27PM  Perrigo Company To Present At Upcoming Healthcare Conferences PR Newswire
04:25PM  Analyst: Mylan Shareholders Might Get Convinced By Vigodman Letter
12:29AM  Mylan Should Try Teva On for Size at The Wall Street Journal
Apr-29-15 06:42PM  Perrigo rejects raised Mylan bid; Teva recommits to Mylan buy
05:40PM  Takeover target triangle: Teva, Mylan & Perrigo
04:44PM  Mylan Raises Its Offer for Generics Counterpart Perrigo at TheStreet
02:36PM  Mylan Should Try Teva On for Size at The Wall Street Journal
01:29PM  Mylan ups Perrigo bid again and gets rejected at MarketWatch
01:29PM  Perrigo Rejects Mylans Increased Offer
01:18PM  Mylan Bumps Up Offer for Perrigo
01:03PM  The PerrigoMylan Proposal Faces some Big Hurdles
01:03PM  Mylan Launches Hostile Bid for Perrigo
12:40PM  Starwood Hotels Explores Possible Sale, and More at MarketWatch
12:33PM  Perrigo rebuffs sweetened $35.6bn offer from Mylan at Financial Times
12:28PM  Mylan Raises Perrigo Bid, But Perrigo Still Says No at Investor's Business Daily
11:56AM  Mylan Boosts Offer for Perrigo to $35.6 Billion at The Wall Street Journal
11:21AM  Perrigo Rejects Latest Mylan Unsolicited Offer at noodls
11:03AM  Perrigo Rejects Latest Mylan Unsolicited Offer PR Newswire
10:51AM  Mylan sweetens offer for Perrigo - again (Video) at
10:42AM  Faber: Perrigo to reject latest Mylan offer
10:28AM  Perrigo (PRGO) Stock Gains After Mylan Increases Takeover Bid at TheStreet
09:31AM  Mylan Raises Offer to Acquire Perrigo at noodls
09:20AM  Mylan Raises Offer to Acquire Perrigo PR Newswire
09:20AM  Mylan raises bid for Perrigo
Apr-28-15 03:40PM  Perrigo Company plc Announces Quarterly Dividend at noodls
02:55PM  Perrigo Company plc Announces Quarterly Dividend PR Newswire
12:06PM  U.S. judge dismisses racketeering claims vs SAC Capital Reuters
09:40AM  Faber Report: Merger tug of war
07:27AM  Teva Gets Bitter Pill From Mylan at The Wall Street Journal
Apr-27-15 09:34PM  Teva Gets Bitter Pill From Mylan at The Wall Street Journal
02:24PM  Mylan says Teva offer too low; criticizes stock, growth prospects
01:10PM  Mylan Rejects $40 Billion Teva Takeover Offer, Calls Stock 'Low-Quality' at Forbes
12:45PM  Mylan Rejects Teva Bid After Raising Bid For Perrigo at Investor's Business Daily
10:58AM  Mylan board turns down Teva bid at
10:03AM  Perrigo Rejects Mylan's Offer Again, Cites Undervaluation - Analyst Blog
09:41AM  Faber Report: Mylan says Teva bid grossly undervalues com...
08:40AM  Perrigo downgraded by B. Riley & Co.
08:30AM  Five things to know today, and how 3G Capital's founder could get big payday when Kraft-Heinz merger closes at
Apr-24-15 05:51PM  Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds at Investor's Business Daily
05:03PM  Mylan makes official bid for Perrigo in generic drug contest
04:06PM  Mylan Inc. -- Moody's: Mylan's Offer for Perrigo Credit Negative but Could be Investment Grade at Moody's
04:05PM  Raised Bid in Three-Way Generic Drug Takeover Battle at The Wall Street Journal
04:00PM  Techs surge on earnings, boosts Nasdaq, S&P 500 to record close at CNBC
03:41PM  Perrigo (PRGO) Stock Declines Today After Rejecting Second Mylan Bid This Week at TheStreet
03:18PM  Deutsche Bank Boosts Mylan's Price Target On This Scenario
01:16PM  Mylan/Perrigo, a more likely combination: Pro
12:46PM  Perrigo rejects formal Mylan takeover offer at Financial Times
12:43PM  $32B deal: Mylan boosts offer for drugmaker Perrigo at USA TODAY
12:28PM  Perrigo Rejects Mylan Unsolicited Offer at noodls
12:09PM  Perrigo Rejects Mylan Unsolicited Offer PR Newswire
11:49AM  Mylan tries to fend off Teva with bigger bid for Perrigo at MarketWatch
11:44AM  Mylan's Formal Offer For Perrigo Will Heat Up Pharma Dealmaking at Forbes
11:35AM  Mylan makes formal bid for Perrigo at
11:03AM  Perrigo (PRGO) Stock Falls Today After Receiving $33 Billion Takeover Offer From Mylan at TheStreet
10:37AM  Mylan lowers price for Perrigo
10:23AM  Mylan ups the ante for Perrigo with $33 billion bid at MarketWatch
10:20AM  Mylan says to commence offer for Perrigo Reuters
10:02AM  Mylan To Commence Formal Offer To Acquire Perrigo For US$60 In Cash And 2.2 Mylan Shares Per Perrigo Share at noodls
09:44AM  Mylan To Commence Formal Offer To Acquire Perrigo For US$60 In Cash And 2.2 Mylan Shares Per Perrigo Share PR Newswire
06:51AM  Epic battles brewing in pharma space
Apr-23-15 03:55PM  Dealpolitik: Three Ways to Look at the Three-Way Pharma Scrum at The Wall Street Journal
02:01PM  What Are the Conditions of the Mylan-Teva Deal?
Apr-22-15 08:17PM  Mylan readies its poison pill defences at Financial Times
05:02PM  Mylan Should Either Find A Friendly Suitor Or Negotiate A Better Deal With Teva at Forbes
02:11PM  Teva Proposes to Buy Mylan, Sends Shares Up - Analyst Blog
02:09PM  The love-hate triangle in pharma
01:38PM  Perrigo Announces The Launch Of A Generic Version Of Kenalog® Topical Spray at noodls
01:18PM  Perrigo (PRGO) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
11:59AM  Analyst Finds Perrigo 'Still Attractive' As Take Out Target
11:51AM  What's Gabelli Saying About Teva Now?
Perrigo Company plc, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API). Its Consumer Healthcare segment offers OTC pharmaceutical products in the areas of analgesics, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, and animal health products, as well as in the areas of feminine hygiene, diabetes care, and dermatological care; and contract manufacturing services. The company's Nutritionals segment offers infant and toddler formula products, infant and toddler foods, as well as vitamins, minerals, and dietary supplement products to retailers, distributors, and consumers. Its Rx Pharmaceuticals segment develops, manufactures and markets a portfolio of Rx drugs in topical dosage forms, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, and powders, as well as controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. This segment provides its products to chain drug stores, wholesalers, distributors, hospital systems, and group purchasing organizations. The company's API segment develops, manufactures, and markets API that are used in the production of pharmaceutical products to generic drug industries and branded pharmaceutical companies. Its Specialty Sciences segment provides Tysabri, which is used for the treatment of Multiple Sclerosis; and Prialt, a non-narcotic intrathecal analgesic. The company also offers pharmaceutical and medical diagnostic products. The company offers its products primarily in the United States, the United Kingdom, Mexico, Israel, and Australia, as well as in Canada, China, and Latin America. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KINGMA TODD WExecutive VP, General CounselApr 29Option Exercise58.821,70099,99411,064May 01 04:19 PM
KINGMA TODD WExecutive VP, General CounselApr 29Sale190.271,700323,4599,364May 01 04:19 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyApr 14Option Exercise107.058,800941,9974,148Apr 16 04:14 PM
HENDRICKSON JOHN TEVP Global Operations & SupplyApr 14Sale200.278,8001,762,3760Apr 16 04:14 PM
KINGMA TODD WExecutive VP, General CounselApr 13Option Exercise35.851,30046,60510,664Apr 15 02:57 PM
KINGMA TODD WExecutive VP, General CounselApr 13Sale198.441,300257,9729,364Apr 15 02:57 PM
Shah JatinSr VP & Chief Scientific OfficMar 13Sale165.502,000331,0003,291Mar 17 10:50 AM
Yu LouisExecutive VP Global QualityMar 12Sale166.2714023,2784,746Mar 16 04:35 PM
Farrington ThomasSenior VP and CIOFeb 20Sale151.1851778,161321Feb 24 04:26 PM
Farrington ThomasSenior VP and CIOFeb 06Option Exercise0.0079801,119Feb 09 04:37 PM
MORRIS HERMAN JRDirectorNov 14Sale154.4220030,8831,400Nov 17 05:22 PM
Kochan SharonEVP, GM InternationalNov 10Option Exercise90.655,367486,51910,767Nov 12 04:37 PM
Kochan SharonEVP, GM InternationalNov 10Sale156.365,367839,1845,400Nov 12 04:37 PM
Yu LouisExecutive VP Global QualityNov 10Sale155.1125940,1734,886Nov 12 04:33 PM
Brown Judy LExecutive VP & CFONov 03Option Exercise48.923,515171,9539,445Nov 05 04:39 PM
Brown Judy LExecutive VP & CFONov 03Sale160.603,515564,5077,445Nov 05 04:39 PM
Brown Judy LExecutive VP & CFOOct 01Option Exercise48.923,515171,9539,445Oct 02 04:26 PM
Brown Judy LExecutive VP & CFOOct 01Sale150.723,515529,7817,445Oct 02 04:26 PM
KINGMA TODD WExecutive VP, General CounselSep 03Sale150.101,000150,0952,000Sep 03 05:00 PM
Kochan SharonEVP, GM InternationalSep 03Sale150.001,116167,4005,400Sep 04 04:42 PM
Farrington ThomasSenior VP and CIOSep 02Sale150.361,741261,773321Sep 03 05:12 PM
KINGMA TODD WExecutive VP, General CounselAug 29Option Exercise35.851,25044,81310,614Sep 03 05:00 PM
KINGMA TODD WExecutive VP, General CounselAug 29Sale149.301,250186,6259,364Sep 03 05:00 PM